Research
-
Life Technologies appoints head of global research and development
Life Technologies announced that Alan B Sachs, MD, PhD, former vice president, exploratory and translational sciences for Merck Research Laboratories, has joined the company as head of global research and development.
Research | 11 April 2012
-
Biosimilars provide cost saving to users, industry
Biosimilars provide significant cost saving to both the users and the industry hence the adoption of these drugs are expected to be higher side.
Research | 24 February 2012
-
Research-based pharmaceutical industry pledges 14 billion treatments to help end nine neglected tropical diseases
The research-based pharmaceutical industry announced donations of 14 billion treatments this decade to support the elimination or control of nine key neglected tropical diseases (NTDs). Averaging 1.4 billion treatments annually, the donations build upon companies’ existing medicines donation programs which already reach millions of people around the world.
Research | 09 February 2012
-
Fentanyl growth set to reach double digits
Greystone Research associates analyze the demographic, economic, pharmaceutical and morbidity factors driving demand.
Research | 30 November 2011
-
ICON names global head of clinical research services
ICON announced that Dr Steve Cutler will join the company as group president, clinical research services. Dr Cutler has over 23 years’ experience within the pharmaceutical and CRO industry and joins ICON from Kendle where he held the position of chief executive officer, having previously served as Kendle’s chief operating officer.
Research | 29 November 2011
-
Thermo Fisher Scientific introduces Nano-UHPLC system
Thermo Fisher Scientific announced that the Center for Experimental Bioinformatics (CEBI) at the University of Southern Denmark is using Thermo Scientific nano-ultra high performance liquid chromatography (UHPLC) technology to accelerate productivity and improve efficiencies during its proteomics research. Implementation of the Thermo Scientific EASY-nLC 1000 has enabled 34 percent more peptide and 22 percent more protein identifications within the CEBI laboratory, significantly increasing productivity. Additionally, the instrument has improved separations and facilitated the analysis of more complex samples within the laboratory.
Research | 25 November 2011
-
Vorapaxar’s data presented at AHA, published in NEJM
Researchers presented and published results from TRACER (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome), the first clinical outcomes trial of vorapaxar, the investigational Protease Activated Receptor 1 (PAR-1) thrombin receptor antagonist from Merck (known as MSD outside the US and Canada).
Research | 18 November 2011
-
Thermo Fisher Scientific screening library advances drug discovery research
20,000-molecule Maybridge collection will help identify compound candidates to treat a wide range of diseases.
Research | 18 October 2011
-
Progenra and Ono Pharmaceutical enter into research collaboration
Progenra will collaborate with Ono to conduct assay development and high throughput screening by using Progenra’s proprietary technology on multiple targets in the ubiquitin pathway.
Research | 12 October 2011
-
Agilent Technologies supports research at the Broad Institute
Developing proteomics technology to detect disease biomarkers.
Research | 12 October 2011
